ESSEX INVESTMENT MANAGEMENT CO LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
ESSEX INVESTMENT MANAGEMENT CO LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$10,788,000
+77.7%
807,424
+86.4%
0.85%
+18.6%
Q3 2018$6,072,000
-10.9%
433,131
-0.0%
0.71%
-16.3%
Q2 2018$6,812,000
-4.7%
433,337
-0.3%
0.85%
-9.3%
Q1 2018$7,150,000
-11.8%
434,624
-3.1%
0.94%
-12.1%
Q4 2017$8,104,000
+38.1%
448,712
+47.6%
1.07%
+34.0%
Q3 2017$5,869,000
+31.3%
304,101
-19.7%
0.80%
+24.7%
Q2 2017$4,470,000
+23.9%
378,846
+15.0%
0.64%
+13.1%
Q1 2017$3,609,000
+114.1%
329,305
+41.8%
0.57%
+103.6%
Q4 2016$1,686,000
+50.4%
232,267
+34.7%
0.28%
+53.6%
Q3 2016$1,121,000172,3890.18%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders